Sign in
8-K/A

Current Report

enGene Therapeutics Inc. Filed Acc 0001193125-25-228331

Executive or director change

  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading engn-20250707.htm…